Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global P2X7 Receptor Antagonists Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global P2X7 Receptor Antagonists Market Status and Forecast (2016-2027)
      • 1.3.2 Global P2X7 Receptor Antagonists Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global P2X7 Receptor Antagonists Supply by Company

    • 2.1 Global P2X7 Receptor Antagonists Sales Value by Company
    • 2.2 P2X7 Receptor Antagonists Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional P2X7 Receptor Antagonists Market Status by Category

    • 3.1 P2X7 Receptor Antagonists Category Introduction
      • 3.1.1 GSK1482160
      • 3.1.2 AZD9056
      • 3.1.3 EVT 401
      • 3.1.4 JNJ 55308942 & JNJ 54175446
      • 3.1.5 AKP-23494954/RQ-00466479
      • 3.1.6 Others
    • 3.2 Global P2X7 Receptor Antagonists Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional P2X7 Receptor Antagonists Market Status by End User/Segment

    • 4.1 P2X7 Receptor Antagonists Segment by End User/Segment
      • 4.1.1 Inflammatory Diseases
      • 4.1.2 Central Nervous System Diseases
      • 4.1.3 Immune System Disorders
    • 4.2 Global P2X7 Receptor Antagonists Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global P2X7 Receptor Antagonists Market Status by Region

    • 5.1 Global P2X7 Receptor Antagonists Market by Region
    • 5.2 North America P2X7 Receptor Antagonists Market Status
    • 5.3 Europe P2X7 Receptor Antagonists Market Status
    • 5.4 Asia Pacific P2X7 Receptor Antagonists Market Status
    • 5.5 Central & South America P2X7 Receptor Antagonists Market Status
    • 5.6 Middle East & Africa P2X7 Receptor Antagonists Market Status

    6 North America P2X7 Receptor Antagonists Market Status

    • 6.1 North America P2X7 Receptor Antagonists Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe P2X7 Receptor Antagonists Market Status

    • 7.1 Europe P2X7 Receptor Antagonists Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific P2X7 Receptor Antagonists Market Status

    • 8.1 Asia Pacific P2X7 Receptor Antagonists Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America P2X7 Receptor Antagonists Market Status

    • 9.1 Central & South America P2X7 Receptor Antagonists Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa P2X7 Receptor Antagonists Market Status

    • 10.1 Middle East & Africa P2X7 Receptor Antagonists Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global P2X7 Receptor Antagonists Market Forecast by Category and by End User/Segment

    • 12.1 Global P2X7 Receptor Antagonists Sales Value Forecast (2022-2027)
    • 12.2 Global P2X7 Receptor Antagonists Forecast by Category
    • 12.3 Global P2X7 Receptor Antagonists Forecast by End User/Segment

    13 Global P2X7 Receptor Antagonists Market Forecast by Region/Country

    • 13.1 Global P2X7 Receptor Antagonists Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 RaQualia Pharma
      • 14.1.1 Company Information
      • 14.1.2 P2X7 Receptor Antagonists Product Introduction
      • 14.1.3 RaQualia Pharma P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 P2X7 Receptor Antagonists Product Introduction
      • 14.2.3 Pfizer P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Janssen
      • 14.3.1 Company Information
      • 14.3.2 P2X7 Receptor Antagonists Product Introduction
      • 14.3.3 Janssen P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 GlaxoSmithKline
      • 14.4.1 Company Information
      • 14.4.2 P2X7 Receptor Antagonists Product Introduction
      • 14.4.3 GlaxoSmithKline P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Evotec
      • 14.5.1 Company Information
      • 14.5.2 P2X7 Receptor Antagonists Product Introduction
      • 14.5.3 Evotec P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 AstraZeneca
      • 14.6.1 Company Information
      • 14.6.2 P2X7 Receptor Antagonists Product Introduction
      • 14.6.3 AstraZeneca P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Asahi Kasei Pharma
      • 14.7.1 Company Information
      • 14.7.2 P2X7 Receptor Antagonists Product Introduction
      • 14.7.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global P2X7 Receptor Antagonists market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global P2X7 Receptor Antagonists market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

        Segmented by Category
        GSK1482160
        AZD9056
        EVT 401
        JNJ 55308942 & JNJ 54175446
        AKP-23494954/RQ-00466479
        Others

        Segmented by End User/Segment
        Inflammatory Diseases
        Central Nervous System Diseases
        Immune System Disorders

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        RaQualia Pharma
        Pfizer
        Janssen
        GlaxoSmithKline
        Evotec
        AstraZeneca
        Asahi Kasei Pharma

        Buy now